Autism is a neurodevelopmental disorder characterized by difficulties in communication and social behavior. Approximately 20% of cases are linked to a specific genetic mutation, but the origin of the remaining 80%, known as idiopathic autism, remains a mystery.
Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW – Biotech Investments
EQS-News: Eckert & Ziegler SE / Key word(s): Regulatory Admission/Market Launch Eckert & Ziegler Submits GalliaPharm® for Approval by Japan’s Health Authority MHLW 13.12.2024 /